Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216766 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL6753279 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL672648 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL6703426 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL9504841 | 0.86 | — | — | |
| SCHEMBL3356662 | 0.86 | TSHR (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL1506892 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL6751743 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL1549779 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL6751742 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TSHRHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2892879-B1 | CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | GOUSSEV DMITRI (CA) | 2020-07-22 | — | — | EP | disclosed |
| US-10112887-B2 | Catalysts based on amino-sulfide ligands for hydrogenation and dehydrogenation processes | GOUSSEV DMITRI (CA) | 2018-10-30 | — | — | US | disclosed |
| US-20170073298-A1 | CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | GOUSSEV DMITRI (CA) | 2017-03-16 | — | — | US | disclosed |
| US-20150202609-A1 | Catalysts based on Amino-Sulfide Ligands for Hydrogenation and Dehydrogenation Processes | GOUSSEV DMITRI (US) | 2015-07-23 | — | — | US | disclosed |
| EP-2892879-A1 | CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | Goussev, Dmitri (CA) | 2015-07-15 | — | — | EP | disclosed |
| WO-2014036650-A1 | CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | GOUSSEV DMITRI (CA) | 2014-03-13 | — | — | WO | disclosed |
| US-6025020-A | IMPREGNATION OF CARBON FIBERS WITH RUTHENIUM OXIDE, DRYING AND HEATING | AUBURN UNIVERSITY | 2000-02-15 | — | — | US | disclosed |
| EP-0055459-A1 | Process for producing oxides using chemical vapour deposition | Rikuun Electric co. (JP) | 1982-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202609-A1 | Catalysts based on Amino-Sulfide Ligands for Hydrogenation and Dehydrogenation Processes | ACSL3, GLUL, FASN | ALDH1A1 483/4885TSHR 1542/4885HSD17B10 46/4885 |
| US-20170073298-A1 | CATALYSTS BASED ON AMINO-SULFIDE LIGANDS FOR HYDROGENATION AND DEHYDROGENATION PROCESSES | ACSL3, GLUL, FASN | ALDH1A1 483/4885TSHR 1542/4885HSD17B10 46/4885 |
| US-10112887-B2 | Catalysts based on amino-sulfide ligands for hydrogenation and dehydrogenation processes | ACSL3, GLUL, FASN | ALDH1A1 483/4885TSHR 1542/4885HSD17B10 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.